Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study
Por um escritor misterioso
Descrição
Frontiers COVID-19 and the potential of Janus family kinase (JAK
Full article: Therapeutic safety and efficacy of triple
Baricitinib Versus Tocilizumab for the Treatment of Moderate to
COVID-19: autoimmunity, multisystemic inflammation and autoimmune
Full article: Therapeutic and anti-inflammatory effects of
Role of baricitinib in COVID-19 patients: A systematic review and
Two Years into the COVID-19 Pandemic: Lessons Learned
Cureus Current Use of Baricitinib in COVID-19 Treatment and Its
Post-COVID-19 interstitial lung disease presenting with profound
de
por adulto (o preço varia de acordo com o tamanho do grupo)
